Cognitive performance and lifetime cannabis use in patients with first-episode schizophrenia spectrum disorder.

M HájkováKarolina KnížkováA SiroňováBarbora Keřková Juraj Jonáš P Šustová A Dorazilová M Rodriguez

Published in: Cognitive neuropsychiatry (2021)

The results delivered supporting evidence for the trend of superior neurocognitive performance in FES patients with a lifetime history of cannabis use compared to non-using patients.

Keyphrases

end stage renal disease
spectrum disorder
bipolar disorder
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors